Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Decibel Therapeutics, Inc. | 20,000 | reported | 11 Feb 2021 | tx 1+20,000 |
| PRUDENTIAL FINANCIAL INC | 11,583 | reported | 12 May 2026 | tx 240+76,249.48−45,367 |
| SHERWIN WILLIAMS CO | 2,573.38 | reported | 04 Apr 2025 | tx 57+6,802.12 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 9+31,430−4,753 |
| REGENERON PHARMACEUTICALS, INC. |
| 1,962 |
| reported |
| 02 Jan 2026 |
| tx 86+245,162−202,753 |
| JOHNSON & JOHNSON | 0 | reported | 13 Feb 2009 | tx 44+835,947−23,372 |
1 purchase reported after at least 12 months of silence — most recent on 21 May 2014.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 12 May 2026 | EXERCISE | PRUDENTIAL FINANCIAL INC | 1,765 | 0.00 USD | |
| 12 May 2026 | OTHER | PRUDENTIAL FINANCIAL INC | 1,765 | 102.58 USD | |
| 12 May 2026 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 1,754 | 0.00 USD | deriv |
| 12 May 2026 | EXERCISE | PRUDENTIAL FINANCIAL INC | 1,765 | 0.00 USD | deriv |
| 12 Mar 2026 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 61 | 92.34 USD | deriv |
| 12 Mar 2026 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 26 | 92.34 USD | deriv |
| 12 Mar 2026 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 201 | 92.34 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 11 Dec 2025 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 151 | 117.05 USD | deriv |
| 11 Dec 2025 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 46 | 117.05 USD | deriv |
| 11 Dec 2025 | GRANT_AWARD | PRUDENTIAL FINANCIAL INC | 19 | 117.05 USD | deriv |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,915 | 654.42 USD | |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,735 | 653.50 USD | |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 650 | 652.68 USD | |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 388 | 657.29 USD | |
| 30 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,712 | 520.01 USD | |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 712 | 656.50 USD | |
| 29 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 6,500 | 520.01 USD | |
| 29 Oct 2025 | SALE | REGENERON PHARMACEUTICALS, INC. | 100 | 655.10 USD | |
| 30 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,712 | 0.00 USD | deriv |
| 29 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 6,500 | 0.00 USD | deriv |